No Data
No Data
Abeona Therapeutics Wins FDA Approval For First-of-Its-Kind Gene Therapy
Abeona Therapeutics Up Over 22%, on Pace for Largest Percent Increase Since October 2022 -- Data Talk
12 Health Care Stocks Moving In Wednesday's Intraday Session
$ABEO Stock Is up 27% Today. Here's What We See in Our Data.
HC Wainwright & Co. Maintains Buy on Abeona Therapeutics, Raises Price Target to $20
Stifel Maintains Abeona Therapeutics(ABEO.US) With Buy Rating, Raises Target Price to $21